An epitranscriptomic mechanism underlies selective mRNA translation remodelling in melanoma persister cells

Abstract Cancer persister cells tolerate anticancer drugs and serve as the founders of acquired resistance and cancer relapse. Here we show that a subpopulation of BRAF V600 mutant melanoma cells that tolerates exposure to BRAF and MEK inhibitors undergoes a reversible remodelling of mRNA translatio... View More